Partner Larry Vernaglia was quoted in a Health System Specialist article, “CMS Proposes Streamlining Regulations to Save Hospitals More Than $1 Billion Annually,” about a variety of proposed rule modifications intended to ease the regulatory burden on hospitals and health care systems.
Vernaglia said the proposals would better allow health care systems to build compliance programs to scale, as opposed to having them placed at virtually every site where they deliver care. “That is a good thing,” he said. “It’s dumb to have to build redundancies and duplicative oversight.”
The proposed rules also would permit flexibility if systems want to take a more cautious path, he added. “If the mother ship has hired the best experts (to implement policies), I’m okay with that,” he said, “but if a local administrator or director of nursing wants to do something different, it is okay.”
Vernaglia said the proposals would better allow health care systems to build compliance programs to scale, as opposed to having them placed at virtually every site where they deliver care. “That is a good thing,” he said. “It’s dumb to have to build redundancies and duplicative oversight.”
The proposed rules also would permit flexibility if systems want to take a more cautious path, he added. “If the mother ship has hired the best experts (to implement policies), I’m okay with that,” he said, “but if a local administrator or director of nursing wants to do something different, it is okay.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”